Breast Circulating Tumor Cells: Potential Biomarkers for Breast Cancer Diagnosis and Prognosis Evaluation
Reference103 articles.
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005;55:74–108.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
3. Boyages J, Chua B, Taylor R, Bilous M, Salisbury E, Wilcken N, et al. Use of the St Gallen classification for patients with node-negative breast cancer may lead to overuse of adjuvant chemotherapy. Br J Surg. 2002;89:789–96.
4. Boyages J, Taylor R, Chua B, Ung O, Bilous M, Salisbury E, et al. A risk index for early node-negative breast cancer. Br J Surg. 2006;93:564–71.
5. Colomer R, Vinas G, Beltran M, Izquierdo A, Lluch A, Llombart-Cussac A, et al. Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM). J Clin Oncol. 2004;22:961–2.